October 9, 2026
avatar-angus-chen
Cancer Reporter

Sometimes I hear from patients that mental health is an overlooked part of their cancer treatment. Cancer, no matter what stage or type, is an incredibly stressful and mentally taxing diagnosis to contend with. Addressing that depression may actually be an important part of improving their outcomes as well, according to a new study presented at the American Society for Radiation Oncology meeting on September 28.

Researchers looked at retrospective data and found that patients who received psychotherapy within a month of cancer diagnosis had a 21% lower risk of dying from cancer. They also found that patients with major depression had a higher risk of dying from cancer, but only 3% of patients with depression received psychotherapy within 4 weeks of getting a cancer diagnosis. That suggests there’s an important unmet need for mental health among cancer patients.

“When depression goes unrecognized or untreated, it can add another layer of difficulty at a time when patients need support the most. Our findings suggest that earlier screening and referral for psychotherapy could help address an important gap in comprehensive cancer care,” said Edmund Qiao, the lead author on the study and a radiation oncology resident at UCSD.


Adobe

STAT+ | Why this startup is taking its AI to predict breast cancer risk directly to patients

A startup says waiting for doctors to prescribe, and insurers to pay for, its breast-cancer risk prediction AI would take too long. So its going directly to patients.

By Katie Palmer


STAT+ | Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines

The deal between the Swiss company and Defand Therapeutics could signal a shift in global development.

By Allison DeAngelis


STAT+ | Merck suffers a setback in Europe over its new Keytruda formulation

At issue are certain enzymes called Mdase that Halozyme developed to enable the administration of drugs by injection.

By Ed Silverman



Caribou Biosciences CEO Rachel Haurwitz
Steve Jennings/Getty Images for TechCrunch

STAT+ | Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down

The company is shutting down after failing to raise the money necessary to fund a late-stage clinical trial of its off-the-shelf CAR-T therapy for lymphoma.

By Adam Feuerstein


More around STAT

In other news

  • Hospital and pharmaceutical prices are smothering America’s businesses, STAT
  • Exercise programs can keep cancer in remission. Why is no one talking about it? New York Times

 
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.